WT-1 mRNA expression is modulated by nitric oxide availabilityand Hsp70 interaction after neonatal unilateral ureteral obstruction

Biocell

Volumn 34, Issue 3, 2010, Pages 121-132

  Mazzei, Luciana ^a   García, Isabel Mercedes ^a   Cacciamani, Valeria ^a   Benardón, María Eugenia ^a   Manucha, Walter ^a,b  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b IMBECU CONICET (National Council of Scientific and Technical Research of Argentina)   (Argentina)

Author keywords

Apoptosis; Kidney development; Obstructive nephropathy; Statins

Indexed keywords

DRUG VEHICLE; HEAT SHOCK PROTEIN 70; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; NITRIC OXIDE; PROTEIN BAX; PROTEIN BCL 2; ROSUVASTATIN; WT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOAVAILABILITY; BODY MASS; CELL STRAIN; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY EPITHELIUM; KIDNEY MASS; MALE; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; UPREGULATION; URETER OBSTRUCTION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL LINE; DISEASE MODELS, ANIMAL; DOGS; ENZYME INHIBITORS; EPITHELIAL CELLS; FEMALE; FLUOROBENZENES; HSP70 HEAT-SHOCK PROTEINS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY; LUMINOL; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OLIGOPEPTIDES; PYRIMIDINES; RATS; RATS, INBRED WKY; SULFONAMIDES; TUMOR SUPPRESSOR PROTEIN P53; URETERAL OBSTRUCTION; WT1 PROTEINS;

RATTUS;

EID: 79952798997     PISSN: 03279545     EISSN: 16675746     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE (1991). Isolation, characterization, and expression of the murine Wilms' tumor gene (WT-1) during kidney development. Molecular and Cellular Biology 11: 1707-1712.
2. Chan W, Krieg RJ Jr, Ward K, Santos F Jr, Lin KC, Chan JC (2001). Progression after release of obstructive nephropathy. Pediatric Nephrology 16: 238-44.
3. Cheng H, Cenciarelli C, Shao Z, Vidal M, Parks WP, Pagano M, Cheng-Mayer C (2001). Human T cell leucemia virus type 1 Tax associates with a molecular chaperone complex containing hTid-1 and Hsp70. Current Biology 11: 1771-1775.
4. Chevalier RL (1998). Pathophysiology of obstructive nephropathy in the newborn. Seminars in nephrology 18: 585-593.
5. Chevalier RL, Thornhill BA, Chang AY, Cachat F, Lackey A (2002). Recovery from release of ureteral obstruction in the rat: relationship to nephrogenesis. Kidney International 61: 2033-2043.
6. Cormack-Aboud FC, Brinkkoetter PT, Pippin JW, Shankland SJ, Durvasula RV (2009). Rosuvastatin protects against podocyte apoptosis in vitro. Nephrology Dialysis and Transplantation 24: 404-412.
7. Cummings MC (1996). Increased p53 mRNA expression in liver and kidney apoptosis. Biochimica et biophysica acta 1315: 100-104.
8. Duran X, Vilahur G, Badimon L (2009). Exogenous in vivo NO-donor treatment preserves p53 levels and protects vascular cells from apoptosis. Atherosclerosis 205: 101-106.
9. Ekblom P (1989). Developmentally regulated conversion of mesenchime to epithelium. The FASEB journal 3: 2141-2160.
10. Elli M, Söylemezoglu O, Erbas D, Bakkaloglu SA, Buyan N, Ozkaya O, Hasanoglu E (2005). Plasma and urine nitric oxide levels in healthy Turkish children. Pediatric Nephrology 20: 1605-1609.
11. Forbes MS, Thornhill BA, Park MH, Chevalier RL (2007). Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury. American Journal of Pathology 170: 87-99.
12. Gianella A, Nobili E, Abbate M, Zoja C, Gelosa P, Mussoni L, Bellosta S, Canavesi M, Rottoli D, Guerrini U, Brioschi M, Banfi C, Tremoli E, Remuzzi G, Sironi L (2007). Rosuvastatin treatment prevents progressive kidney inflammation and fibrosis in stroke-prone rats. American Journal of Pathology 170: 1165-1177.
13. Goloubinoff P, De Los Rios P (2007). The mechanism of Hsp70 chaperones: (entropic) pulling the models together. Trends in biochemical sciences 32: 372-380.
14. Griess JO (1864). On a new series of in which nitrogen is substituted for hydrogen. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 154: 667-731.
15. Hegarty NJ, Watson RW, Young LS, O'Neill AJ, Brady HR, Fitzpatrick JM (2002). Cytoprotective effects of nitrates in a cellular model of hydronephrosis. Kidney International 62: 70-77.
16. Ito K, Chen J, Seshan SV, Khodadadian JJ, Gallagher R, El Chaar M, Vaughan Jr ED, Poppas DP, Felsen D (2005). Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats. Kidney International 68: 515-528.
17. Jäättelä M (1999). Escaping cell death: survival proteins in cancer. Experimental cell research 248: 30-43.
18. Johannesen J, Karlsen AE, Pociot F, Roenn SG, Nerup J (2003). Strain dependent rat iNOS promoter activity-correlation to identified WT-1 transcription factor binding site. Autoimmunity 36: 167-175.
19. Kawaguchi M, Koshimura K, Murakami Y, Tsumori M, Gonda T, Kato Y (1999). Antihypertensive effect of insulin via nitric oxide production in the Zucker diabetic fatty rat, an animal model for non-insulin-dependent diabetes mellitus. European Journal of Endocrinology 140: 341-349.
20. Kim YM, Bombeck CA, Billiar TR (1999). Nitric oxide as a bifunctional regulator of apoptosis. Circulation Research 84: 253-256.
21. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R (1993). WT-1 is required for early kidney development. Cell 74: 679-691.
22. Lane DP, Midgley C, Hupp T (1993). Tumour suppressor genes and molecular chaperones. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 339: 369-372.
23. Li F, Mao HP, Ruchalski KL, Wang YH, Choy W, Schwartz JH, Borkan SC (2002). Heat stress prevents mitochondrial injury in ATP-depleted renal epithelial cells. American Journal of Physiology Cell Physiology 283: 917-926.
24. Liapis H (2003). Biology of congenital obstructive nephropathy. Nephron. Experimental nephrology 93: 87-91.
25. Maheswaran S, Englert C, Bennett P, Heinrich G, Haber DA (1995). The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Development 9: 2143-56.
26. Maheswaran S, Englert C, Zheng G, Lee SB, Wong J, Harkin DP, Bean J, Ezzell R, Garvin AJ, McCluskey RT, DeCaprio JA, Haber DA (1998). Inhibition of cellular proliferation by the Wilms tumor suppressor WT-1 requires association with the inducible chaperone Hsp70. Genes Development 12: 1108-1120.
27. Manucha W (2007). Biochemical-molecular markers in unilateral ureteral obstruction. Biocell 31: 1-12.
28. Manucha W, Carrizo L, Ruete C, Molina H, Vallés P (2005). Angiotensin II type I antagonist on oxidative stress and heat shock protein 70 (Hsp 70) expression in obstructive nephropathy. Cellular and Molecular Biology 51: 547-555.
29. Manucha W, Oliveros L, Carrizo L Seltzer A, Vallés P (2004). Losartan modulation on NOS isoforms and COX-2 expression in early renal fibrogenesis in unilateral obstruction. Kidney International 65: 2091-2107.
30. Manucha W, Vallés PG (2008). Cytoprotective role of nitric oxide associated with Hsp70 expression in neonatal obstructive nephropathy. Nitric Oxide 18: 204-215.
31. Marcet-Palacios M, Davoine F, Adamko DJ, Moqbel R, Befus AD (2007). Human lymphocytes express the transcriptional regulator, Wilms tumor 1: the role of WT-1 in mediating nitric oxide-dependent repression of lymphocyte proliferation. Biochemical and biophysical research communications 363: 283-287.
32. Mayo MW, Wang CY, Drouin SS, Madrid LV, Marshall AF, Reed JC, Weissman BE, Baldwin AS (1999). WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 protooncogene. EMBO Journal 18: 3990-4003.
33. Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, Vaughan ED, Felsen D (2000). Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney International 58: 2301-2313.
34. Miyajima A, Chen J, Poppas DP, Vaughan Jr ED, Felsen D (2001). Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney International 59: 1290-1303.
35. 2 receptor blockade on the pathogenesis of renal fibrosis. American Journal of Physiology 276: F39-F45.
36. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D (1990). The candidate Wilms tumor gene is involved in genitourinary development. Nature 346: 194-197.
37. Scharnhorst V, Dekker P, van der Eb AJ, Jochemsen AG (2000). Physical interaction between Wilms tumor 1 and p53 proteins modulates their functions. The Journal of biological chemistry 275 (14): 10202-10211.
38. Schlaich MP, Oehmer S, Schneider MP, Delles C, Schmidt BM, Schmieder RE (2007). Effects of nitric oxide synthase inhibition and L-Arginine on renal haemodynamics in young patients at high cardiovascular risk, Atherosclerosis. 192: 155-160.
39. Shepherd J, Hunninghake DB, Stein EA, Kastelein JJ, Harris S, Pears J, Hutchinson HG (2004). Safety of rosuvastatin. American Journal of Cardiology 94: 882-888.
40. Takenaka IM, Leung SM, McAndrew SJ, Brown JP, Hightower LE (1995). Hsc70-binding peptides selected from a phage display peptide library that resemble organellar targeting sequences. The Journal of Biological Chemistry 270: 19839-19844.
41. Topcu SO, Celik S, Erturhan S, Erbagci A, Yagci F, Ucak R (2008). Verapamil prevents the apoptotic and hemodynamic changes in response to unilateral ureteral obstruction. International Journal of Urology 15: 350-355.
42. Trnka P, Hiatt MJ, Ivanova L, Tarantal AF, Matsell DG (2010). Phenotypic transition of the collecting duct epithelium in congenital urinary tract obstruction. Journal of Biomedicine & Biotechnology 696034. Epub 2009.
43. Vasil'eva TV, Michurina TV, Radionova IuV, Kuzin BA, Enikolopov GN, Khrushchov NG (1997). NO synthetase in the cells of different tissues and organs of the mouse. Ontogenez 28: 458-462.
44. Xu Q, Hu Y, Kleindienst R, Wick G (1997). Nitric oxide induces heat-shock protein 70 expression in vascular smooth muscle cells via activation of heat shock factor 1. Journal of Clinical Investigation 100: 1089-1097.
45. Yoo KH, Thornhill BA, Forbes MS, Chevalier RL (2010). Induciblenitric oxide synthase modulates hydronephrosis following partial or complete unilateral ureteral obstruction in the neonatal mouse. American Journal of Physiology Renal Physiology 298: F62-F71.
46. Zhou MS, Schuman IH, Jaimes EA, Raij L (2008). Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. American Journal of Physiology Renal Physiology 295: F53-F59.